Ajami Tarek, Musquera Mireia, Palou Joan, Guru Khurshid A, Hussein Ahmed Aly, Eun Daniel, Hosseini Abolfazl, Gaya Josep Maria, Abaza Ronney, Iqbal Umar, Lee Randall, Lee Ziho, Lee Matthew, Raventos Carles, Breda Alberto, Lozano Fernando, Trilla Enrique, Vigués Francesc, Carrion Albert
Hospital Clinic de Barcelona, Barcelona, Spain.
Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.
World J Urol. 2025 Jan 16;43(1):74. doi: 10.1007/s00345-024-05435-x.
Open ureteroenteric reimplantation (OUER) of ureteroenteric strictures (UESs) is related to important morbidity. Robot-assisted ureteroenteric reimplantation (RUER) has been proposed to provide similar outcomes with lower morbidity. We aimed to compare perioperative and functional outcomes between RUER and OUER.
A retrospective multicenter study of 80 patients, who underwent 82 ureteroenteric reimplantations (17 OUER vs 65 RUER) at 8 institutions between 2009-2021 for benign UESs after radical cystectomy. All the open procedures were performed by the same center in order to compare the robotic approach with a standardized technique. Data were reviewed for demographics, stricture characteristics, and perioperative outcomes. Complication and stricture recurrence rates were compared between both groups.
Among 82 reimplantations, 44 were left sided (54%) and 12 bilateral (14%). Median time from cystectomy to diagnosis of stricture was 6 months (range 3-18). Baseline characteristics (gender, age, BMI, side, type of urinary diversion and previous abdominal radiotherapy) were comparable between RUER and OUER groups, except for ASA score and rates of prior robotic cystectomy. The 30-day overall postoperative complication rate was 37% in RUER compared to 70.6% in OUER (p = 0.026). Patients who underwent a RUER had statistically significant lower rate of intraoperative blood transfusion (0% vs 12%, p = 0.041), urinary tract infection (12% vs 53%, p < 0.001), bowel injury (0% vs 12%, p = 0.041) and high-grade complications (Clavien III-IV) (4.6% vs 23.5%, p = 0.031). RUER patients had shorter median length of hospital stay (3 days IQR[1-6] vs 6 IQR[3-9], p = 0.018) and lower readmission rate (4.6% vs 29.4%, p = 0.008). After a median follow-up of 23.5 months (8.7-43), 80% of RUER cases were stricture free compared to 90% of OUER (p = 0.42).
RUER achieved a success rate comparable to that of open revisions and may provide some advantages in terms of perioperative outcomes. Prospective and larger studies are warranted to prove its superiority compared to the standard open technique.
输尿管肠道狭窄(UES)的开放性输尿管肠道再植术(OUER)与严重的发病率相关。已提出机器人辅助输尿管肠道再植术(RUER)以提供相似的结果且发病率更低。我们旨在比较RUER和OUER的围手术期及功能结果。
一项回顾性多中心研究,纳入了80例患者,他们于2009年至2021年期间在8家机构接受了82例输尿管肠道再植术(17例OUER vs 65例RUER),用于根治性膀胱切除术后的良性UES。所有开放性手术均由同一中心进行,以便将机器人手术方法与标准化技术进行比较。对人口统计学、狭窄特征和围手术期结果的数据进行了审查。比较了两组之间的并发症和狭窄复发率。
在82例再植术中,44例为左侧(54%),12例为双侧(14%)。从膀胱切除到狭窄诊断的中位时间为6个月(范围3 - 18个月)。RUER组和OUER组之间的基线特征(性别、年龄、BMI、侧别、尿流改道类型和既往腹部放疗)具有可比性,但ASA评分和既往机器人辅助膀胱切除术的发生率除外。RUER组术后30天总体并发症发生率为37%,而OUER组为70.6%(p = 0.026)。接受RUER的患者术中输血率(0% vs 12%,p = 0.041)、尿路感染率(12% vs 53%,p < 0.001)、肠道损伤率(0% vs 12%,p = 0.041)和高级别并发症(Clavien III - IV级)发生率(4.6% vs 23.5%,p = 0.031)在统计学上显著更低。RUER组患者的中位住院时间更短(3天,IQR[1 - 6] vs 6天,IQR[3 - 9],p = 0.018),再入院率更低(4.6% vs 29.4%,p = 0.008)。中位随访23.5个月(8.7 - 43个月)后,RUER病例的80%无狭窄,而OUER为90%(p = 0.42)。
RUER取得了与开放性修复相当的成功率,并且在围手术期结果方面可能具有一些优势。需要进行前瞻性和更大规模的研究以证明其与标准开放性技术相比的优越性。